Corrigendum: Soluble PD−L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysis

• Takashi Shimizu,
• Takashi Shimizu,
• Eisuke Inoue,
• Ryotaro Ohkuma,
• Ryotaro Ohkuma,
• Shinichi Kobayashi,
• Takuya Tsunoda,
• Satoshi Wada,
• Satoshi Wada,
• Satoshi Wada,
• Satoshi Wada,
• Satoshi Wada

Affiliations

Takashi Shimizu

Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan

Takashi Shimizu

Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan

Eisuke Inoue

Showa University Research Administration Center, Showa University, Tokyo, Japan

Ryotaro Ohkuma

Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan

Ryotaro Ohkuma

Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan

Shinichi Kobayashi

Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan

Takuya Tsunoda

Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan

Satoshi Wada

Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan

Satoshi Wada

Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan

Satoshi Wada

Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan

Satoshi Wada

Department of Pharmacology, School of Medicine, Showa University, Tokyo, Japan

Satoshi Wada

Pharmacological Research Center, Showa University, Tokyo, Japan